Candida species are frequently isolated and may be associated with high mortality in the absence of appropriate treatment (
36). Persistent candidiasis is widely documented as a reason for mortality and morbidity in hospitals and also responsible for the most common nosocomial bloodstream infection (
37-
40). The majority of yeast infection cases are caused by
C. albicans (
39). Inherent resistance to antifungal treatment has been observed in a few species, but is emerging as a prominent problem in the management of
Candida infections (
41). Recently, the incidence of diseases caused by drug-resistant fungi has increased. To treat contagious fungal infections Amphotericin B has been used, but it is acknowledged to have high and potentially dangerous side effects, counting the occurrence of high fever and trembling anxieties later a hours of infusion (
42).
The general side effects of antifungal drugs include kidney damage, gastrointestinal discomfort, skin complaints, and hepatotoxicity (
43). Hence, there is a necessity to identify novel drugs from diverse natural sources (
44). Mostly, endophytic bacteria produce diverse dynamic compounds with special biological activities (
45). To this end, the present study evaluated the anticandidal effects of endophytic bacteria isolates from
D. uniformis against 5
Candida species,
C. albicans (KACC 30062),
C. albicans (KACC 30003),
C. glabrata (KBNO6P00368), C.
saitoana (KACC 41238), and
C. geochares (KACC 30061).
Several researchers have isolated various endophytes from different parts of plants. Bacterial endophytes have been documented as storehouse of new secondary metabolites for possible remedial use (
46-
49). According to Strobel and Daisy (
50), the study of endophytes of medicinal and widespread fern plants is required as they are anticipated to harbor unique and exciting endophytes with new bioactive metabolites. The growth of availability of antifungal compounds from natural products has encouraged search for superior efficiency strategies, like using the antifungal agents from edible medicinal plants (
40).
This has directed to the detection of quite a lot of bioactive composites from bacterial as well as fungal endophytes isolated from medicinal and fern plants (
48,
51-
54). Several species in the
Bacillus genus are economically significant for use in the construction of numerous molecules and additional products for foodstuffs, pharmaceutical, agricultural, and biological industries (
55,
56). Several
Bacillus species are remarkably important owing to their use in antibiotic construction and ability to induce production of anti-inflammatory cytokine in vitro (
57-
59). The use of
Bacillus species to produce a wide range of metabolites having antimicrobial prospective is extensive in the medical and pharmaceutical industries; they can assist plant growth in adverse conditions and also capable of controlling many infections in humans, animals, and plants after applied as an organic control mediator (
60-
62).
Paenibacillus sp. are known for their endophytic existence (
14,
63) and have been described as capable plant-growth promoting bacteria (
64). Numerous
Paenibacillus-based products have been patented and commercially established. The antagonistic prospective of
Paenibacillus sp. against a wide range of phytopathogenic fungi has been previously acknowledged (
65,
66). As a source of novel bioactive compounds,
Paenibacillus sp. strains have a huge potential in biotechnology; at present, this potentially has only partially been explored (
67).
Burkholderia is a group of metabolically important gram negative bacteria (
68). Various
Burkholderia species are acknowledged for their metabolic prospective and be able to be used for biotechnological functions, for instance the biological management of plant infections (
69), nodulation as well as plant development elevation (
70,
71), and bioremediation (
72,
73). Promising application of endophytic bacteria to the natural control of pathogenic fungi and in the plant growth improvement was reported in the previous study of Zhao et al (
64).
Scanning electron microscopy analysis results revealed variations in the morphology of tested pathogenic
C. albicans (KACC 30062) strain with respect to the control with the smooth, regular oval shape and the high density cells. These variations in the morphological feathers in the treated
C. albicans (KACC 30062) might arise from the bioactive compounds extracted from the butanol extract from the endophytic bacteria that resulted in the destruction of cell integrity and lysis of the cell wall as evidenced from earlier findings (
21).
5.1. Conclusion
In the present study, we screened a large number of endophytic bacteria from D. uniformis and confirmed that six endophytic bacteria displayed promising anticandidal effects against four Candida species. Two of these bacteria showed strong anticandidal activity against C. saitoana, C. albicans, and C. glabrata species; three showed strong anticandidal activity against two C. albicans species. One of the selected endophytic bacteria, Burkholderia sp. UR 1-07, which showed clear and highest anticandidal activity against C. albicans (KACC 30062), was used for further solvent extraction. The butanolic fraction was effective against C. albicans (KACC 30062). Thus, it was concluded that endophytic bacteria isolated from D. uniformis may serve as the potential source of natural anticandidal agents useful for the inhibition of the Candida species C. saitoana (KACC 41238), C. albicans (KACC 30062), C. albicans (KACC 30003), and C. glabrata (KBNO6P00368). It may also be a substitute for artificial fungicides to control candidiasis.